scholarly journals Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study

2017 ◽  
Vol 23 (4) ◽  
pp. 182-193 ◽  
Author(s):  
Stella Welter ◽  
Caroline Lücke ◽  
Alexandra Philomena Lam ◽  
Christina Custal ◽  
Sebastian Moeller ◽  
...  
2018 ◽  
pp. cebp.0123.2018 ◽  
Author(s):  
Jennifer L. Beebe-Dimmer ◽  
Terrance L Albrecht ◽  
Tara E. Baird ◽  
Julie J Ruterbusch ◽  
Theresa Hastert ◽  
...  

2012 ◽  
Vol 18 (6) ◽  
pp. 427-433 ◽  
Author(s):  
Henry N. Young ◽  
S. Nadra Havican ◽  
Sara Griesbach ◽  
Joshua M. Thorpe ◽  
Betty A. Chewning ◽  
...  

1999 ◽  
Vol 23 (1) ◽  
pp. 22-24 ◽  
Author(s):  
Justin H. G. Williams

Aims and methodAn audit was performed to look at how carefully anticholinergic medication was prescribed and monitored in a population of psychiatric patients on depot medication.ResultsThe mean duration of prescription was 47 months and 44% of patients' prescriptions went unaltered for over three years. Evidence was lacking for rational initial anticholinergic prescription.Clinical implicationsAnticholinergic treatment needs to be prescribed more rationally with regular monitoring of extra-pyramidal symptoms.


Sign in / Sign up

Export Citation Format

Share Document